The findings that metformin blocked vascular invasion of thyroid tumors of ThrbPV/PVPten+/−mice are in line with the reports in which the anti-angiogenic effects of metformin were described in colon cancer [39], HER2+ tumor cells [40] and breast tumors [41, 42]. This evidence concerns the gene ERBB2 and breast neoplasm.